Star Source Multi Trade share news and announcements
BSE: 506365Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹108.30.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹16 Cr4,271st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 12.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −0.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −3.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,049
Star Source Multi Trade share news and announcements
469 announcements, routine notices left out, newest first. Page 3 of 10.
Oct 2024
11 Oct · Legal
Exchange has sought clarification from Chemo Pharma Laboratories Ltd on October 11, 2024 with reference to significant movement in price, in order to ensure that investors have latest ....8 Oct · Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Sep 2024
Jul 2024
9 Jul · Board meeting
Meeting on 29 Jul 2024: annual general meeting and quarterly results
May 2024
27 May · Board meeting
15 May · Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
10 May · Board meeting
Meeting on 27 May 2024: audited results
Apr 2024
11 Apr · Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024
5 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2024
2 Apr · Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Jan 2024
9 Jan · Board meeting
Meeting on 29 Jan 2024: quarterly results
Oct 2023
16 Oct · Board meeting
Meeting on 27 Oct 2023: quarterly results9 Oct · Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Sep 2023
Jul 2023
14 Jul · Board meeting
Meeting on 27 Jul 2023: quarterly results
Jun 2023
12 Jun · Intimation Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
May 2023
15 May · Board meeting
Meeting on 24 May 2023: audited results
Apr 2023
17 Apr · Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2023
13 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2023.
Jan 2023
5 Jan · Board meeting
Meeting on 31 Jan 2023: quarterly results